Altered adenosine-to-inosine RNA editing in human cancer

Genome Research

Volumn 17, Issue 11, 2007, Pages 1586-1595

  Paz, Nurit ^a,b   Levanon, Erez Y ^c,h   Amariglio, Ninette ^a,b   Heimberger, Amy B ^d   Ram, Zvi ^e   Constantini, Shlomi ^e   Barbash, Zohar S ^a,b   Adamsky, Konstantin ^a   Safran, Michal ^a,b   Hirschberg, Avi ^a,b   Krupsky, Meir ^a,b   Ben Dov, Issachar ^a,b   Cazacu, Simona ^f   Mikkelsen, Tom ^f   Brodie, Chaya ^f,g   Eisenberg, Eli ^b   Rechavi, Gideon ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Compugen Ltd ^*  (Israel)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^f HENRY FORD HOSPITAL   (United States)

^g NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; INOSINE;

ADAR GENE; ADARB1 GENE; ADARB2 GENE; ALU SEQUENCE; ARTICLE; BIOINFORMATICS; BRAIN TUMOR; CANCER GENETICS; CANCER GRADING; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIGENETICS; GENE; GENE CONTROL; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TUMOR; LUNG TUMOR; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROSTATE TUMOR; RNA ANALYSIS; RNA EDITING; TESTIS TUMOR;

ADENOSINE; ADENOSINE DEAMINASE; ALU ELEMENTS; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; HUMANS; INOSINE; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS; RNA EDITING; RNA PRECURSORS; RNA, UNTRANSLATED;

EID: 35948957777     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.6493107     Document Type: Article

References (49)

1. Athanasiadis, A., Rich, A., and Maas, S. 2004. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol. 2: e391. doi: 10.1371/journal.pbio.0020391.
2. Bass, B.L. 2002. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 71: 817-846.
3. Bhalla, K.N. 2005. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. J. Clin. Oncol. 23: 3971-3993.
4. Blow, M., Futreal, P.A., Wooster, R., and Stratton, M.R. 2004. A survey of RNA editing in human brain. Genome Res. 14: 2379-2387.
5. Blow, M.J., Grocock, R.J., van Dongen, S., Enright, A.J., Dicks, E., Futreal, P.A., Wooster, R., and Stratton, M.R. 2006. RNA editing of human microRNAs. Genome Biol. 7: R27.
6. Boulton, S.J. 2006. BRCA1-mediated ubiquitylation. Cell Cycle 5: 1481-1486.
7. Brusa, R., Zimmermann, F., Koh, D.S., Feldmeyer, D., Gass, P., Seeburg, P.H., and Sprengel, R. 1995. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 270: 1677-1680.
8. Ceballos, E., Munoz-Alonso, M.J., Berwanger, B., Acosta, J.C., Hernandez, R., Krause, M., Hartmann, O., Eilers, M., and Leon, J. 2005. Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes. Oncogene 24: 4559-4571.
9. Chen, C.X., Cho, D.S., Wang, Q., Lai, F., Carter, K.C., and Nishikura, K. 2000. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 6: 755-767.
10. Cheng, C.K., Chow, L.W., Loo, W.T., Chan, T.K., and Chan, V. 2005. The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer. Cancer Res. 65: 8646-8654.
11. Clutterbuck, D.R., Leroy, A., O'Connell, M.A., and Semple, C.A. 2005. A bioinformatic screen for novel A-I RNA editing sites reveals recoding editing in BC10. Bioinformatics 21: 2590-2595.
12. Coons, S.W., Johnson, P.C., Scheithauer, B.W., Yates, A.J., and Pearl, D.K. 1997. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79: 1381-1393.
13. Eisenberg, E., Nemzer, S., Kinar, Y., Sorek, R., Rechavi, G., and Levanon, E.Y. 2005. Is abundant A-to-I RNA editing primate-specific? Trends Genet. 21: 77-81.
14. Feinberg, A.P. and Vogelstein, B. 1983. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92.
15. Feinberg, A.P., Ohlsson, R., and Henikoff, S. 2006. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7: 21-33.
16. Fernandez, H.R., Kavi, H.H., Xie, W., and Birchler, J.A. 2005. Heterochromatin: On the ADAR radar? Curr. Biol. 15: R132-R134.
17. Gourzi, P., Leonova, T., and Papavasiliou, F.N. 2006. A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity 24: 779-786.
18. Gromova, I., Gromov, P., and Celis, J.E. 2002. bc10: A novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer. Int. J. Cancer 98: 539-546.
19. Gurevich, I., Tamir, H., Arango, V., Dwork, A.J., Mann, J.J., and Schmauss, C. 2002. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34: 349-356.
20. Hartner, J.C., Schmittwolf, C., Kispert, A., Muller, A.M., Higuchi, M., and Seeburg, P.H. 2004. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J. Biol. Chem. 279: 4894-4902.
21. Higuchi, M., Maas, S., Single, F.N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R., and Seeburg, P.H. 2000. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406: 78-81.
22. Kawahara, Y., Ito, K., Sun, H., Aizawa, H., Kanazawa, I., and Kwak, S. 2004. Glutamate receptors: RNA editing and death of motor neurons. Nature 427: 801.
23. Kim, D.D., Kim, T.T., Walsh, T., Kobayashi, Y., Matise, T.C., Buyske, S., and Gabriel, A. 2004. Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res. 14: 1719-1725.
24. Levanon, E.Y., Eisenberg, E., Yelin, R., Nemzer, S., Hallegger, M., Shemesh, R., Fligelman, Z.Y., Shoshan, A., Pollock, S.R., Sztybel, D., et al. 2004. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 22: 1001-1005.
25. Levanon, E.Y., Hallegger, M., Kinar, Y., Shemesh, R., Djinovic-Carugo, K., Rechavi, G., Jantsch, M.F., and Eisenberg, E. 2005a. Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res. 33: 1162-1168. doi: 10.1093/nar/gki239.
26. Levanon, K., Eisenberg, E., Rechavi, G., and Levanon, E.Y. 2005b. Letter from the editor: Adenosine-to-inosine RNA editing in Alu repeats in the human genome. EMBO Rep. 6: 831-835.
27. Loy, C.J., Sim, K.S., and Yong, E.L. 2003. Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc. Natl. Acad. Sci. 100: 4562-4567.
28. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A., et al. 2005. MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
29. Luciano, D.J., Mirsky, H., Vendetti, N.J., and Maas, S. 2004. RNA editing of a miRNA precursor. RNA 10: 1174-1177.
30. Maas, S., Patt, S., Schrey, M., and Rich, A. 2001. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc. Natl. Acad. Sci. 98: 14687-14692.
31. Monni, O., Barlund, M., Mousses, S., Kononen, J., Sauter, G., Heiskanen, M., Paavola, P., Avela, K., Chen, Y., Bittner, M.L., et al. 2001. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc. Natl. Acad. Sci. 98: 5711-5716.
32. Neeman, Y., Levanon, E.Y., Jantsch, M.F., and Eisenberg, E. 2006. RNA editing level in the mouse is determined by the genomic repeat repertoire. RNA 12: 1802-1809.
33. Nie, Y., Hammond, G.L., and Yang, J.H. 2006. Double stranded RNA deaminase ADAR1 increases host susceptibility to virus infection. J. Virol. 81: 917-923.
34. Palladino, M.J., Keegan, L.P., O'Connell, M.A., and Reenan, R.A. 2000. A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity. Cell 102: 437-449.
35. Patterson, J.B. and Samuel, C.E. 1995. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: Evidence for two forms of the deaminase. Mol. Cell. Biol. 15: 5376-5388.
36. Prasanth, K.V., Prasanth, S.G., Xuan, Z., Hearn, S., Freier, S.M., Bennett, C.F., Zhang, M.Q., and Spector, D.L. 2005. Regulating gene expression through RNA nuclear retention. Cell 123: 249-263.
37. Rae, F.K., Stephenson, S.A., Nicol, D.L., and Clements, J.A. 2000. Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display. Int. J. Cancer 88: 726-732.
38. Sardi, I., Dal Canto, M., Bartoletti, R., and Montali, E. 1997. Abnormal c-myc oncogene DNA methylation in human bladder cancer: Possible role in tumor progression. Eur. Urol. 31: 224-230.
39. Scadden, A.D.J. and O'Connell, M.A. 2005. Cleavage of dsRNAs hyper-edited by ADARs occurs at preferred editing sites. Nucleic Acids Res. 33: 5954-5964. doi: 10.1093/nar/gki909.
40. Schenck, A., Bardoni, B., Langmann, C., Harden, N., Mandel, J.L., and Giangrande, A. 2003. CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron 38: 887-898.
41. Smalheiser, N.R. and Torvik, V.I. 2006. Alu elements within human mRNAs are probable microRNA targets. Trends Genet. 22: 532-536.
42. Su, H.C., Zhao, Y.H., Fan, D.G., Fan, Q.Y., Zhang, P., Wen, Y.H., and Liu, Y.Y. 2003. Relationship between expression of BLCAP protein and malignancy of osteosarcoma. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 19: 465-466.
43. Su, A.I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K.A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. 101: 6062-6067.
44. Tonkin, L.A. and Bass, B.L. 2003. Mutations in RNAi rescue aberrant chemotaxis of ADAR mutants. Science 302: 1725.
45. Wang, Q., Khillan, J., Gadue, P., and Nishikura, K. 2000. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290: 1765-1768.
46. Welcsh, P.L. and King, M.C. 2001. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 10: 705-713.
47. Yamanaka, S., Balestra, M.E., Ferrell, L.D., Fan, J., Arnold, K.S., Taylor, S., Taylor, J.M., and Innerarity, T.L. 1995. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. 92: 8483-8487.
48. Yang, W., Chendrimada, T.P., Wang, Q., Higuchi, M., Seeburg, P.H., Shiekhattar, R., and Nishikura, K. 2006. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 13: 13-21.
49. Yao, J., Duan, L., Fan, M., Yuan, J., and Wu, X. 2007. Overexpression of BLCAP induces S phase arrest and apoptosis independent of p53 and NF-kappaB in human tongue carcinoma: BLCAP overexpression induces S phase arrest and apoptosis. Mol. Cell. Biochem. 297: 81-92.